Tipifarnib enhances eradication of acute myeloid leukemia by altering CXCL12/CXCR4 signaling in AML and by modifying the bone marrow microenvironment
Year: 2021
Type: conference-abstract
Source: The Journal of Immunology
Institutions: Mayo Clinic, Kura Oncology (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4320061634
